Poly Medicure Limited has submitted a regulatory filing to the BSE Limited and the National Stock Exchange of India Limited. The disclosure is made pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The filing intimates that officials of the company will be participating in the "Avendus Spark INDX - Annual Investor Conference". The details of the meeting with analysts and institutional investors are as follows:
Event Name: Avendus Spark INDX - Annual Investor Conference
Meeting Date: Wednesday, 18th November 2026
Venue: In Person, Mumbai
Meeting Format: One-on-one / Group Meeting
The company notes that this schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company itself. A critical disclaimer states that no Unpublished Price Sensitive Information (UPSI) will be shared during this meeting.
The letter is signed by Avinash Chandra, Company Secretary (Membership No. A32270), on behalf of Poly Medicure Limited.